Search research articles
Contact Us
Filters
Showing results (111-120 of 1,075) with videos related to
Page
of 108
Sort By:
International Journal of Sport Nutrition and Exercise Metabolism
|
April 27, 2007
Postexercise carbohydrate-protein- antioxidant ingestion decreases plasma creatine kinase and muscle soreness
Nicholas D Luden, Michael J Saunders, M Kent Todd
Topics in Stroke Rehabilitation
|
November 26, 2013
Development of a self-report scale of spasticity
Steve Barker, Mike Horton, Ruth M Kent, et al.
Biological Psychiatry
|
November 10, 1998
Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety
J M Kent, J D Coplan, J M Gorman
British Heart Journal
|
October 1, 1979
Syndrome of valvular pulmonary stenosis and valvular aortic stenosis with atrial septal defect
R J Shemin, K M Kent, W C Roberts
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 18, 2002
The mechanism-based inactivation of human cytochrome P450 2B6 by phencyclidine
Monica I Jushchyshyn, Ute M Kent, Paul F Hollenberg
The American Journal of Cardiology
|
December 17, 2003
Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy
Daniel W Isenbarger, Steven M Kent, Patrick G O'Malley
The Journal of Pharmacology and Experimental Therapeutics
|
December 21, 2004
The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5
Hsia-lien Lin, Ute M Kent, Paul F Hollenberg
Chest
|
April 12, 2005
Exercise testing in Wolff-Parkinson-White syndrome: case report with ECG and literature review
Matthew R Jezior, Steven M Kent, J Edwin Atwood
Chemical Research in Toxicology
|
December 7, 2007
Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications
Paul F Hollenberg, Ute M Kent, Namandjé N Bumpus
Trials
|
May 24, 2008
Competing risk and heterogeneity of treatment effect in clinical trials
David M Kent, Alawi Alsheikh-Ali, Rodney A Hayward
Page
of 108
Search research articles
Search
Showing results (111-120 of 1,075) with videos related to
Sort By:
Page
of 108
International Journal of Sport Nutrition and Exercise Metabolism
|
April 27, 2007
Postexercise carbohydrate-protein- antioxidant ingestion decreases plasma creatine kinase and muscle soreness
Nicholas D Luden, Michael J Saunders, M Kent Todd
Topics in Stroke Rehabilitation
|
November 26, 2013
Development of a self-report scale of spasticity
Steve Barker, Mike Horton, Ruth M Kent, et al.
Biological Psychiatry
|
November 10, 1998
Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety
J M Kent, J D Coplan, J M Gorman
British Heart Journal
|
October 1, 1979
Syndrome of valvular pulmonary stenosis and valvular aortic stenosis with atrial septal defect
R J Shemin, K M Kent, W C Roberts
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
December 18, 2002
The mechanism-based inactivation of human cytochrome P450 2B6 by phencyclidine
Monica I Jushchyshyn, Ute M Kent, Paul F Hollenberg
The American Journal of Cardiology
|
December 17, 2003
Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy
Daniel W Isenbarger, Steven M Kent, Patrick G O'Malley
The Journal of Pharmacology and Experimental Therapeutics
|
December 21, 2004
The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5
Hsia-lien Lin, Ute M Kent, Paul F Hollenberg
Chest
|
April 12, 2005
Exercise testing in Wolff-Parkinson-White syndrome: case report with ECG and literature review
Matthew R Jezior, Steven M Kent, J Edwin Atwood
Chemical Research in Toxicology
|
December 7, 2007
Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications
Paul F Hollenberg, Ute M Kent, Namandjé N Bumpus
Trials
|
May 24, 2008
Competing risk and heterogeneity of treatment effect in clinical trials
David M Kent, Alawi Alsheikh-Ali, Rodney A Hayward
Page
of 108